Global 200+ Billion Drug and Medical Device Development Outsourcing Market to 2025

DUBLIN, Sept. 14, 2020 /PRNewswire/ -- The "Global Drug and Medical Device Development Outsourcing Market 2020: Focus on Services and Technologies" report has been added to ResearchAndMarkets.com's offering.

The global outsourcing services market for drug and medical device development is expected to grow from £130.5 billion in 2020 to £205.6 billion by 2025 with a compound annual growth rate (CAGR) of 9.5% for the period of 2020-2025.

This report represents a current and important business tool to evaluate technologies, trends, products and market participants in the outsourcing sector for drug and medical device development. The geographic scope of this study covers the U.S. and companies worldwide.

Outsourcing has become one of the main strategies to reduce the cost and time of drug or device development. For example, there are contract research organizations (CROs) that specialize in the drug discovery stage, offering solutions for target screening, validation and lead optimization. Other companies focus on animal studies, pharmacokinetics or assay development.

Contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs) are also essential parts of the drug development process. These companies supply manufacturing services for different stages of preclinical and clinical research. Formulation development and bioanalytical testing are also outsourced to variety of vendors.

To conduct clinical trials, many medium-size and small biotech companies outsource specific activities such as study design, patient recruitment and other associated services. Medical device development represents a unique sector due to its specific design, regulatory and manufacturing needs. Overall, the outsourcing market can be viewed and analyzed by different stage of drug/device development process.

Importantly, pharma companies have different outsourcing needs than smaller biotech and start-ups. In sum, each development activity can be outsourced to vendors with the required experience and knowledge.

This report will describe current trends, products, evolving technologies and new services in the outsourcing industry for drug and medical device development. It will evaluate current situation and forecast possible outcomes of this market for the next five years.

The report includes:

• An overview of the global outsourcing market for drug and medical device development and discussion on their services and technologies
• Analyses of global market trends, with data from 2018, 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
• Identification of key challenges and opportunities in the drug and medical device development market and coverage of products and services related to different sectors of the industry
• Information on ISO, GLP, cGMP regulatory aspects in drug development and discussion on their importance related to certification of specific facilities
• A look at the ongoing activities in drug and device development process, their budget, timeline, resources and processes
• Insights into regulatory framework, investment analysis, growth indicators and key decision supporting factors and evaluation of current market size, market forecast, and market share analysis of the leading players of the industry
• Comprehensive profiles of major players in the industry, including Sterling Medical Devices, Evotec SE, Ajinomoto Althea, Eurofins Scientific, Charles River Laboratories Inc and DeviceLab

Market Projections

• The global outsourcing services market for drug and medical device development is expected to grow from 130.5 billion pounds in 2020 to 205.6 billion pounds by 2025 with a compound annual growth rate (CAGR) of 9.5% for the period of 2020-2025.
• The global outsourcing services market for preclinical stage is expected to grow from 67.5 billion pounds in 2020 to 106 billion pounds by 2025 with a compound annual growth rate (CAGR) of 9.4% for the period of 2020-2025.
• The global outsourcing services for medical device development market is expected to grow from 30 billion pounds in 2020 to 50 billion pounds by 2025 with a compound annual growth rate (CAGR) of 10.8% for the period of 2020-2025.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Background

• Overall Drug Development Process Overview: From Discovery to Commercialization
• Drug Development Outsourcing Market Overview

Chapter 4 Drug Discovery Outsourcing

• Drug Discovery Process Overview
• Target Identification and Validation
• Target Identification and Validation Market Overview and Estimate
• Biaffin
• Biognosys
• Creative Biolabs
• Evotec
• Pelago Bioscience
• REPROCELL
• Market Summary
• Hit Generation and Selection
• Animal Immunization and Hybridoma Generation.
• Microbial/Phage Display
• Eukaryotic Ribosome Display
• Single B Cell
• Hit Generation and Selection Drug Discovery Services Market Overview and Estimate
• GenScript Biotech Corp.
• I-MAb
• NovAlix
• SARomics Biostructures
• Taros
• Lead Optimization
• Lead Optimization Drug Discovery Services Market Overview and Estimate
• AMRI (Albany Molecular Research Inc.)
• BioDuro
• Charles River Laboratories
• IRBM
• Medicilon
• NJ Biopharmaceuticals
• Provid Pharmaceuticals
• Drug Discovery Stage Outsourcing Services Market Estimates

Chapter 5 Preclinical Drug Development Outsourcing Market

• Preclinical Process Overview and Outsourcing
• Drug Substance/Active Pharmaceutical Ingredient (API) Manufacturing Market for Drug Development
• Almac Group
• AmbioPharm
• Avara Pharmaceutical Services
• Bachem
• Biopeptek Pharmaceuticals
• Cambrex Corp.
• PCI Synthesis (Novacap)
• PolyPeptide Group
• Lonza
• Luina Bio
• WuXi Biologics
• VxP Biologics
• Cognate BioServices
• Market Estimate for Outsourcing API Manufacturing for Drug Development
• Formulation and Dosage Design Outsourcing Services Market
• Ascendia Pharmaceuticals
• Evonik Health Care
• Metrics Contract Services/Mayne Pharma
• PYRAMID Laboratories
• Recipharm Laboratories
• UPM Pharmaceuticals
• Market Overview and Estimates for Outsourcing of Formulation Development
• Analytical/Bioanalytical Methods Development, Validation and Testing
• Analytical Methods Development
• Analytical Methods Validation, Verification and Qualification
• Analytical Testing Method Development and Validation Market Landscape and Estimates
• Alcami Corp.
• Avomeen Analytical Services
• Charles River Laboratories
• Eurofins Scientific
• Recro Gainesville
• Metabolism, Pharmacokinetics and Toxicology Outsourcing
• Absorption Systems
• Alliance Pharma
• Covance
• Noble Life Sciences
• Pacific BioLabs
• Metabolism, Pharmacokinetics and Toxicology Outsourcing Services Market Estimates
• Clinical Trial Material Manufacturing and Testing
• Ajinomoto Althea
• Avid BioServices
• Bioserv Corp.
• Emergent BioSolutions
• IRISYS
• Patheon
• Release and Stability Testing
• ACTA Laboratories
• Nelson Labs
• R.D. Laboratories
• STERIS
• Clinical Trial Material Manufacturing and Testing Outsourcing Market Estimates
• Preclinical Stage Outsourcing Services Market Estimates

Chapter 6 Clinical Stage in the Drug Development Outsourcing Market

• Clinical Stage Process Overview and Outsourcing
• Clinical Stage Outsourcing Services Market Landscape and Estimates
• Clinipace
• IQVIA
• Quanticate
• Parexel International
• PRA Health Sciences
• Premier Research
• Synteract

Chapter 7 Medical Device Development Outsourcing Market

• Medical Device Development Overview
• Outsourcing of Medical Device Development Process
• Medical Device Development Outsourcing Market Participants
• Boston Engineering
• Cirtec Medical
• DeviceLab
• Freudenberg Medical
• Omnica Corp.
• Plexus
• Sterling Medical Devices
• Viant Medical
• Centaur Clinical
• Emergo by UL
• Medpace
• Pacific Bridge Medical
• Qserve CRO
• Medical Device Development Outsourcing Market Estimates

Chapter 8 Consulting Services Outsourcing Market

• Overview of Consulting Services for Drug and Medical Device Development
• Market Landscape and Estimates for Consulting Services for Drug and Medical Device Development
• CMC Pharmaceuticals
• Pacific-Link Regulatory Consulting
• Syner-G Pharma Consulting

Chapter 9 Patent Review for Drug and Medical Device Development Outsourcing Market

Chapter 10 Market Summary

• Overview
• Market Participants
• Market Estimates

Chapter 11 Company Profiles

• Absorption Systems
• Ajinomoto Althea
• Almac Group
• Avomeen Analytical Services
• Bioserv Corp.
• Charles River Laboratories
• Covance
• DeviceLab
• Evotec SE
• Eurofins Scientific
• Genscript Biotech Corp.
• Lonza
• Pacific Biolabs
• PRA Health Sciences
• Sterling Medical Devices

For more information about this report visit https://www.researchandmarkets.com/r/vwdo5a

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com